The T.I.G.C. has developed a series of Clinical Guides developed to help the clinician keep up-to-date with the management of thromboembolic disease. These Clinical Guides are developed by TIGC members, based on a review of the medical literature, when possible guidelines are evidence based, represent a consensus view of the TIGC membership and are adapted to Canadian medical practice.

Disclaimer: This site is designed as a resource for the health care professional. Please note that these recommendations must be viewed as general clinical guides based on current knowledge. Their application must be adapted to individual patients. The Thrombosis Interest Group assumes no responsibility or liability arising from any error or omission or from the use of any information contained herein.

Guidelines for Antithrombotic Therapy Fifth Edition 2005
Hirsh J. Guidelines for Antithrombotic Therapy, 5/e (English version). BC Decker Inc: Hamilton, 2005.

Category Clinical Guides Adobe pdf
Antiplatelet
Therapy
Antiphospholipids
Cancer and
Thrombosis
Central Lines
Diagnosis
DVT
Duration of
Anticoagulation
Heparin
Inferior Vena
Cava Filters

 

INR
Low Molecular
Weight Heparin
(LMWH)
MI
Pediatrics
Pregnancy
Prevention
Pulmonary
Embolism
Stroke
Thrombophilia/
Hypercoagulable
States
Thrombolytic
Therapy
VTE
Warfarin

TIGC Publications

  1. INR reporting in Canadian medical laboratories: a Thrombosis Interest Group of Canada survery. Am J Hematol 1995;48:237-239.
  2. INR reporting in Canadian medical laboratories: an update. Am J Clin Pathol 1998:589-594.
  3. A cross-Canada survey of prothrombin time testing. Does the establishment of local ISI values improve the accuracy of International Normalized Ratio reporting? Am J Clin Pathol 1998;110:683-690.
  4. A survey of APTT reporting in Canadian medical laboratories: the need for increased standardization. Am J Clin Pathol in press.